Skip to content

Condition

Genetic Hearing Loss

Treatments and trials tagged Genetic Hearing Loss, with the same country and access zoom as New Developments.

All New Developments

Genetic Hearing Loss breakthroughs

FDA ApprovedUnited States

First FDA-Approved Gene Therapy for Genetic Hearing Loss

OTARMENI (lunsotogene parvec-cwha) — gene therapy for severe genetic hearing loss from biallelic OTOF variants

FDA accelerated approval on 23 April 2026 for OTARMENI (lunsotogene parvec-cwha) suspension — a one-time intracochlear gene therapy — for…

This is for children and adults with severe genetic hearing loss from confirmed OTOF gene changes who may be…